Skip to content
10-K

Annual Report

Pharma-Bio Serv, Inc. PBSV

0001654954-26-000710

← back to feed
Filed
Jan 29, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 23, 2026 22.9M sh
Shares Diluted FY 2025 · Oct 31, 2025 22.96M sh
Shares Diluted FY 2025 · Oct 31, 2024 22.97M sh
Stock Repurchased FY 2025 · Oct 31, 2025 $31.44K
Stock Repurchased FY 2025 · Oct 31, 2024 $11.26K
Dividends Paid FY 2025 · Oct 31, 2025 $1.72M
Dividends Paid FY 2025 · Jan 28, 2025 $1.72M
Dividends Paid FY 2025 · Oct 31, 2024 $1.72M
Capex FY 2025 · Oct 31, 2025 $6.64K
Capex FY 2025 · Oct 31, 2024 $159.74K
Operating Cash Flow FY 2025 · Oct 31, 2025 −$214.89K
Operating Cash Flow FY 2025 · Oct 31, 2024 −$566.7K
Stockholders Equity FY 2025 · Oct 31, 2025 $11.91M
Stockholders Equity FY 2025 · Oct 31, 2024 $13.72M
Stockholders Equity FY 2025 · Oct 31, 2023 $16.13M
Current Liabilities FY 2025 · Oct 31, 2025 $1.74M
Current Liabilities FY 2025 · Oct 31, 2024 $1.89M
Total Liabilities FY 2025 · Oct 31, 2025 $1.74M
Total Liabilities FY 2025 · Oct 31, 2024 $2.58M
Current Assets FY 2025 · Oct 31, 2025 $13.39M
Current Assets FY 2025 · Oct 31, 2024 $15.7M
Total Assets FY 2025 · Oct 31, 2025 $13.65M
Total Assets FY 2025 · Oct 31, 2024 $16.29M
Eps Diluted FY 2025 · Oct 31, 2025 −$0.00
Eps Diluted FY 2025 · Oct 31, 2024 −$0.03
Sga Expense FY 2025 · Oct 31, 2025 $3.55M
Sga Expense FY 2025 · Oct 31, 2024 $3.8M
Net Income FY 2025 · Oct 31, 2025 −$100.46K
Net Income FY 2025 · Oct 31, 2024 −$777.62K
Operating Income FY 2025 · Oct 31, 2025 −$637.66K
Operating Income FY 2025 · Oct 31, 2024 −$1.29M
Gross Profit FY 2025 · Oct 31, 2025 $2.91M
Gross Profit FY 2025 · Oct 31, 2024 $2.52M
Cost Of Revenue FY 2025 · Oct 31, 2025 $6.09M
Cost Of Revenue FY 2025 · Oct 31, 2024 $6.99M
Revenue FY 2025 · Oct 31, 2025 $9M
Revenue FY 2025 · Oct 31, 2024 $9.51M